Related Experiment Video
Updated: Mar 29, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Practical considerations in genomic decision support: The eMERGE experience.
Timothy M Herr1, Suzette J Bielinski2, Erwin Bottinger3
1Department of Preventive Medicine, Division of Health and Biomedical Informatics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Implementing pharmacogenomics (PGx) into clinical decision support (CDS) is achievable. Most delays in PGx CDS implementation stem from general IT issues, not PGx-specific challenges, making it comparable to other healthcare IT projects.
Area of Science:
- Genomic Medicine
- Clinical Informatics
- Translational Science
Background:
- Genomic medicine offers personalized treatment strategies, with pharmacogenomics (PGx) identified as a key area for implementation.
- Clinical Decision Support (CDS) systems are crucial for integrating PGx at the point of care.
- While theoretical models exist, practical experiences and challenges of PGx CDS implementation are less documented.
Purpose of the Study:
- To analyze real-world experiences of implementing pharmacogenomics Clinical Decision Support (PGx CDS).
- To identify unanticipated challenges encountered during PGx CDS implementation across multiple healthcare sites.
- To assess the feasibility and common barriers in integrating genomic data into clinical workflows.
Main Methods:
- Analysis of implementation experiences from eleven sites within the Electronic Medical Records and Genomics (eMERGE) Network.
- Examination of PGx CDS system characteristics.
- Survey of sites to identify unanticipated implementation challenges.
Main Results:
- Ten sites successfully implemented at least one PGx CDS rule.
- Most sites utilized an Omic Ancillary System (OAS) for managing genomic data.
- Common and impactful delays were attributed to general IT issues like team coordination and staffing, rather than PGx-specific problems, leading to a median go-live delay of two months.
Conclusions:
- Barriers to PGx CDS implementation are surmountable.
- PGx CDS implementation challenges are comparable to other healthcare IT projects.
- These findings encourage institutions to pursue PGx CDS implementation for advancing genomic medicine.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
08:03Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
Published on: December 7, 2021
Related Concept Videos
Evolutionary Relationships through Genome Comparisons
Genomics
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...